There are 3 papers on portal vein thrombosis in aging research: 2 observational studies in people, 1 review.
3 papers study it1 finding
See all 3 papers on portal vein thrombosis
“reverse effects between portal vein thrombosis and PhenoAge (IVW: OR 0.871, 95% CI 0.765-0.992, P = 0.037)”
- Humans2
Effects
1PhenoAge
downin humans1OR 0.871
1 study
PhenoAge
downin humans1OR 0.871
Portal vein thrombosis is linked with lower PhenoAge in humans (OR 0.871, 95% CI 0.765-0.992).
Humans
Trial sponsors
2 trialsPhase 4192 people
Qilu Hospital of Shandong University
2 trialsPhase 4150 people
Asian Institute Of Medical Sciences
1 trialPhase 4220 people
1 trialPhase 4100 people
1 trialPhase 421 people
Academic and Community Cancer Research United
1 trialPhase 3300 people
Università degli Studi dell'Insubria
1 trialPhase 3100 people
First Affiliated Hospital of Zhejiang University
1 trialPhase 354 people
Latest
1 paper in 12 monthsJournal of Hepatocellular Carcinoma
HCC Is the Predominant Liver-Related Event in MASLD: 2-Step Non-Invasive Algorithms to Stratify Risk in Non-Cirrhotic Patients
Cohort study of 352 peopleMetabolic dysfunction-associated steatotic liver disease
Clinical Epigenetics
Causal associations between epigenetic age and thromboembolism: a bi-directional two-sample Mendelian randomization study
Mendelian randomization in peopleVenous thromboembolism
Asian Journal of Andrology
Testosterone replacement therapy and vascular thromboembolic events: a systematic review and meta-analysis
Meta-analysis of studies in peopleTestosterone